{
    "nct_id": "NCT03113617",
    "official_title": "68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer",
    "inclusion_criteria": "* Biopsy proven prostate adenocarcinoma\n* Planned prostatectomy with lymph node dissection\n* Intermediate to high-risk disease (as determined by elevated PSA [PSA > 10], T-stage [T2b or greater], Gleason score [Gleason score > 6] or other risk factors)\n* Able to provide written consent\n* Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent)\n* Diagnostic CT or magnetic resonance imaging (MRI) performed within 30 days prior to the 68Ga-RM2 PET\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 19 Years",
    "exclusion_criteria": "* Inability to lie still for the entire imaging time (approximately 30 minutes)\n* Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)\n* Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance",
    "miscellaneous_criteria": ""
}